All data are based on the daily closing price as of July 17, 2024
b

Bioneer

064550.KQ
25.84 USD
-0.54
-2.05%

Overview

Last close
25.84 usd
Market cap
570.93M usd
52 week high
55.57 usd
52 week low
18.34 usd
Target price
N/A usd

Valuation

P/E
N/A
Forward P/E
N/A
Price/Sales
2.6485
Price/Book Value
3.1128
Enterprise Value
471.52M usd
EV/Revenue
2.4681
EV/EBITDA
63.1164

Key financials

Revenue TTM
162.84M usd
Gross Profit TTM
125.71M usd
EBITDA TTM
20.56M usd
Earnings per Share
N/A usd
Dividend
N/A usd
Total assets
243.89M usd
Net debt
N/A usd

About

Bioneer Corporation engages in the biotechnology research products, molecular diagnosis, drugs, and probiotics businesses in South Korea. The company offers PCR and RT-PCR, real-time PCR, RNAi, chemicals, plastic consumables, and buffer solutions; and sample preparation, protein synthesis and purification, gene cloning, fluorescence dye and quencher, electrophoresis, genome-wide functional analysis, and magnetic separation services, as well as instruments for conventional PCR, real-time PCR, sample preparation, protein synthesis, centrifuge and vortex mixer, electrophoresis, spectrophotometer, and microbial culture. It also provides molecular diagnosis, including MDx technologies, human diagnostics kits, MDx extraction kits, and instruments; and products for animal diseases and nano-bio products. The company was founded in 1992 and is headquartered in Daejeon, South Korea.
  • Symbol
    064550.KQ
  • Exchange
    KQ
  • Isin
    KR7064550007
  • Country
    South Korea
  • Sector
    Healthcare
  • Industry
    Biotechnology & Medical Research
  • CEO
    Han-Oh Park
  • Headquarter
    Daejeon
  • Web site
    https://www.bioneer.co.kr
Jakota Newsletter

Stay ahead in the JAKOTA stock markets with our roundup of vital insights

Icon scroll to top